Depression

Serotonin & Depression

By July 5, 2026 No Comments
Young woman smiling outdoors wearing sunglasses, embracing a carefree summer vibe.

Depression is increasingly recognized as a multi-systemic condition, arising from a complex interplay of biological, psychological, environmental, and genetic factors (Bains et al., 2023). Beyond shifts in neurotransmitters, depression is influenced by chronic inflammation, immune activation, nutrient deficiencies, gut microbiome imbalance, and dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, the body’s primary stress-response system (Bertollo et al., 2025l ; Maes et al., 1997). These interconnected disruptions impede neuroimmune signaling, synaptic plasticity, and cortical connectivity, contributing to low mood, diminished motivation, cognitive rigidity, and emotional dysregulation.

Among neurotransmitters, serotonin plays a central role in emotional balance, cognitive flexibility, stress resilience, and appetite regulation. Deficits in serotonin synthesis, receptor sensitivity, or reuptake are strongly linked to depressive symptoms, anxiety, and heightened stress vulnerability (Shu et al., 2025; Young, 2007). As 90% of serotonin is produced in the gut, microbiome health and gut–brain communication greatly influences serotonergic tone and overall mood regulation (Shu et al., 2025).

SeroPlus by Pure Encapsulations is designed to provide targeted, multi-pathway support for serotonin metabolism and function. By combining bioavailable precursors, receptor sensitizers, reuptake modulators, and enzymatic cofactors, SeroPlus addresses upstream biochemical mechanisms underlying depressive symptoms—promoting serotonin balance across both the brain and body.

Mechanisms and Ingredients Supporting Serotonin Function

Serotonin Synthesis and Precursors

  • 5-HTP (Griffonia simplicifolia): Directly bypasses the rate-limiting step in serotonin synthesis, increasing central serotonin availability. Clinical studies show 5-HTP improves stress-related mood symptoms and enhances BDNF and platelet serotonin, markers of serotonergic function (Emanuele et al., 2010).
  • L-5-MTHF (Metafolin®), Vitamin B6 (pyridoxal 5’-phosphate), Magnesium: Bioavailable cofactors that enable enzymatic reactions for serotonin production. Magnesium supports tryptophan hydroxylase activity, while L-5-MTHF and B6 aid methylation and conversion of 5-HTP to serotonin (Passeri et al., 1993; Doll et al., 1989).

Receptor Sensitization and Signaling

  • Myo-inositol: Enhances serotonin receptor responsiveness and downstream signaling, optimizing neural communication and mood regulation. Clinical evidence indicates myo-inositol can exert SSRI-like effects in depression and premenstrual dysphoric disorder (Gianfranco et al., 2011).

Synaptic Stability and Reuptake Regulation

  • Taurine, Zinc (picolinate), Niacinamide (Vitamin B3): Modulate serotonin release, reuptake, and receptor dynamics. Taurine supports synaptic homeostasis, zinc enhances antidepressant response and NMDA receptor-mediated serotonin signaling, and niacinamide facilitates NAD⁺-dependent metabolism while exerting stress-buffering effects (Becquet et al., 1993;Nowak et al., 2003; Prousky, 2005).

Protection from Oxidative and Inflammatory Stress

  • Vitamin C, Zinc, Magnesium: Act as antioxidants and cofactors, mitigating oxidative damage and neuroinflammation that can impair serotonergic pathways, preserving mood and cognitive function (de Oliveira et al., 2015)(Nowak et al., 2003).

Gut–Brain Axis Support

SeroPlus enhances serotonin production in the gut, supporting healthy gut–brain communication to support emotional balance, stress regulation, cognitive flexibility, and overall well-being.

Clinical Implications

By supporting these interconnected mechanisms, SeroPlus offers broad-spectrum benefits:

  • Positive mood & emotional stability: Enhanced serotonin synthesis and receptor function reduce depressive symptoms and support emotional regulation.
  • Stress resilience & HPA-axis balance: Taurine, niacinamide, and enzymatic cofactors buffer stress signaling, regulate cortisol, and reduce inflammation.
  • Cognitive flexibility & executive function: Gut–brain serotonin signaling, antioxidants, and cofactors preserve synaptic plasticity, supporting attention, memory, and adaptive coping.
  • Appetite regulation: Balanced serotonergic activity promotes healthy feeding behavior and emotional stability.

Suggested Use

Take 2 capsules, 1–2 times daily, between meals. Consistent use supports sustained serotonin production, receptor function, gut–brain communication, and stress-axis regulation.

In Short

Depression is a multi-system condition involving serotonin deficits, HPA-axis dysregulation, inflammation, and gut–brain imbalance. SeroPlus combines bioavailable serotonin precursors, enzymatic cofactors, receptor sensitizers, reuptake modulators, and antioxidants to restore serotonin synthesis, receptor function, and gut–brain communication. This multi-pathway support helps promote positive mood and stress resilience from a body and mind perspective.

Learn More About SeroPlus

Discover a personalized, whole-body plan to find and fix the root causes of your depression in Dr. Greenblatt’s newest book, Finally Hopeful.

Learn More & Purchase

References

  • Bains N, Abdijadid S. Major Depressive Disorder. [Updated 2023 Apr 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559078/
  • Bertollo AG, Santos CF, Bagatini MD, Ignácio ZM. Hypothalamus-pituitary-adrenal and gut-brain axes in biological interaction pathway of the depression. Front Neurosci. 2025 Feb 6;19:1541075. doi: 10.3389/fnins.2025.1541075. PMID: 39981404; PMCID: PMC11839829.
  • Maes M, De Vos N, Demedts P, Wauters A, Neels H. Lower serum zinc in major depression in relation to changes in serum acute phase proteins. J Affect Disord. 1999 Dec;56(2-3):189-94. doi: 10.1016/s0165-0327(99)00011-7. PMID: 10701476.
  • Shu Y, Tian L, Wang X, Meng T, Yu S, Li Y. Decoding serotonin: the molecular symphony behind depression. Front Cell Neurosci. 2025 Apr 24;19:1572462. doi: 10.3389/fncel.2025.1572462. PMID: 40342516; PMCID: PMC12058683.
  • Maes M, Smith R, Christophe A, et al. (1997) Lower serum zinc in major depression is a sensitive marker of treatment resistance and immune activation. Biol Psychiatry, 42(5):349–58.
  • Young SN. How to increase serotonin in the human brain without drugs. J Psychiatry Neurosci. 2007 Nov;32(6):394-9. PMID: 18043762; PMCID: PMC2077351.
  • Emanuele E, Bertona M, Minoretti P, Geroldi D. (2010) An open-label trial of L-5-hydroxytryptophan in subjects with romantic stress. Neuro Endocrinol Lett, 31(5):663–6. PMID:21178946.
  • Passeri M, Cucinotta D, Abate G, et al. (1993) Oral 5′-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study. Aging (Milano), 5(1):63–71. doi:10.1007/BF03324128. PMID:8257478.
  • Doll H, Brown S, Thurston A, Vessey M. (1989) Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial. J R Coll Gen Pract, 39(326):364–8. PMID:2558186; PMCID:PMC1711872.
  • Gianfranco C, Vittorio U, Silvia B, Francesco D. (2011) Myo-inositol in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol, 26(7):526–30. doi:10.1002/hup.1241. PMID:22031267.
  • Becquet D, Hery M, Francois-Bellan AM, Giraud P, Deprez P, Faudon M, Fache MP, Hery F. Glutamate, GABA, glycine and taurine modulate serotonin synthesis and release in rostral and caudal rhombencephalic raphe cells in primary cultures. Neurochem Int. 1993 Sep;23(3):269-83. doi: 10.1016/0197-0186(93)90118-o. PMID: 7693110.
  • Prousky JE. (2005) Nutritional and orthomolecular approaches to stress. J Orthomol Med, 20(3):167–78.
  • de Oliveira IJ, de Souza VV, Motta V, Da-Silva SL. (2015) Effects of oral vitamin C supplementation on anxiety in students: a double-blind, randomized, placebo-controlled trial. Pak J Biol Sci, 18(1):11–8. doi:10.3923/pjbs.2015.11.18. PMID:26353411.
  • Nowak G, Siwek M, Dudek D, Zieba A, Pilc A. (2003) Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol, 55(6):1143–7. PMID:14730113.